Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Women with MS may have increased subclinical disease activity during pregnancy

Publish date:: October 1, 2020

Key clinical point: During pregnancy and the postpartum period, women with multiple sclerosis have increased levels of serum neurofilament light.

Major finding: Serum neurofilament light levels were 22% higher during pregnancy and post partum, compared with before and after this period.

Study details: An analysis of data for 63 participants in the prospective Swiss MS Cohort Study.

Disclosures: The study was conducted without external funding. Dr. Yaldizli has served on advisory boards for Sanofi Genzyme, Novartis, Biogen, and Novartis.

Citation:

Yaldizli Ö et al. MSVirtual2020.

This Week's Must Reads

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Study links sleep meds and dementia risk in older adults,

Childhood Hodgkin survivors have neurocognitive impairment,

Obesity, hypoxia predict severity in children with COVID-19,

Long-term safety and efficacy of teriflunomide for relapsing MS,

Must Reads in Multiple Sclerosis

Long-term safety and efficacy of teriflunomide for relapsing MS,

Newer DMTs are more effective than injectable DMTs in pediatric MS,

Neutrophil granulocyte markers may distinguish between demyelinating diseases,

Bacteria may be associated with risk of MS relapse,

Women with MS may have increased subclinical disease activity during pregnancy,